Last update Feb. 19, 2015

Levodropropizine

Low Risk

Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Non-opioid cough relief medication.

At latest update, relevant published data on excretion into breast milk were not found.

Pharmacokinetic characteristics (low molecular weight, low protein-binding capacity) would favour that it may be excreted into breast milk in significant amount.

Until more information on it is available, safer options are preferred, especially when the infant is a newborn or in case of prematurity.

Otherwise whenever used, the lower effective dose as possible and for the shortest time is recommended. Follow-up for somnolence and feeding troubles should be warranted.

Alternatives

  • Dextromethorphan ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Levodropropizine is also known as


Group

Levodropropizine belongs to this group or family:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 75 %
Molecular weight 236 daltons
Protein Binding 11 - 14 %
VD 3.4 l/Kg
Tmax 0.4 - 0.9 hours
T½ 21 - 2 hours

References

  1. AEMPS. Levodropropizina. Ficha técnica. 2014 Full text (in our servers)
  2. Levodropropizine. Drug Summary. 2014 Full text (in our servers)
  3. Jang JW, Seo JH, Jo MH, Lee YJ, Cho YW, Yim SV, Lee KT. Relative bioavailability of levodropropizine 60 mg capsule and syrup formulations in healthy male Korean volunteers: a singledose, randomized-sequence, open-label, two-way crossover study. Int J Clin Pharmacol Ther. 2013 Abstract
  4. Sangil Jeon, Jongtae Lee, Taegon Hong, Jeongki Paek, Seunghoon Han, Dong-Seok Yim. Pharmacokinetics and Safety of Levodropropizine Controlled Release Tablet after Repeated Dosing in Healthy Male Volunteers. J Korean Soc Clin Pharmacol Ther 2013;21(2):113-119. 2013 Full text (link to original source) Full text (in our servers)
  5. Banderali G, Riva E, Fiocchi A, Cordaro CI, Giovannini M. Efficacy and tolerability of levodropropizine and dropropizine in children with non-productive cough. J Int Med Res. 1995 Abstract

Total visits

90,925

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM